Birdwatch Note
2024-10-16 00:48:50 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Apesar do grande avanço, isso não significa que Musk tenha encontrado a cura para a cegueira. A FDA aprovou como "dispositivo inovador", uma categoria para projetos q buscam melhorar a qualidade de vida de pacientes. Ainda não houve testes em humanos, apenas em macacos. https://oglobo.globo.com/economia/tecnologia/noticia/2024/09/19/dispositivo-inovador-agencia-de-saude-dos-eua-aprova-chip-cerebral-com-promessa-de-devolver-visao-a-cegos-entenda.ghtml https://www.cnnbrasil.com.br/tecnologia/cientistas-contestam-alegacao-de-elon-musk-sobre-implante-para-turbinar-visao/ https://www.tecmundo.com.br/ciencia/289678-neuralink-ganha-aprovacao-implante-cerebral-restaura-visao.htm
Written by 102CADDD3B98759FBE62C77AEBFF70341DD33E606E19CA1D384AEB498BA8CEBE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1846209969445597499
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1846352567942459685
- noteId - 1846352567942459685
- participantId -
- noteAuthorParticipantId - 102CADDD3B98759FBE62C77AEBFF70341DD33E606E19CA1D384AEB498BA8CEBE Participant Details
- createdAtMillis - 1729039730426
- tweetId - 1846209969445597499
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Apesar do grande avanço, isso não significa que Musk tenha encontrado a cura para a cegueira. A FDA aprovou como "dispositivo inovador", uma categoria para projetos q buscam melhorar a qualidade de vida de pacientes. Ainda não houve testes em humanos, apenas em macacos. https://oglobo.globo.com/economia/tecnologia/noticia/2024/09/19/dispositivo-inovador-agencia-de-saude-dos-eua-aprova-chip-cerebral-com-promessa-de-devolver-visao-a-cegos-entenda.ghtml https://www.cnnbrasil.com.br/tecnologia/cientistas-contestam-alegacao-de-elon-musk-sobre-implante-para-turbinar-visao/ https://www.tecmundo.com.br/ciencia/289678-neuralink-ganha-aprovacao-implante-cerebral-restaura-visao.htm
Note Ratings
| rated at | rated by | |
| 2024-10-17 17:06:44 -0500 | Rating Details | |
| 2024-10-16 21:08:42 -0500 | Rating Details | |
| 2024-10-16 20:15:25 -0500 | Rating Details | |
| 2024-10-16 15:07:28 -0500 | Rating Details | |
| 2024-10-16 14:29:10 -0500 | Rating Details | |
| 2024-10-16 11:30:55 -0500 | Rating Details | |
| 2024-10-16 07:33:51 -0500 | Rating Details | |
| 2024-10-16 06:02:25 -0500 | Rating Details | |
| 2024-10-15 23:06:10 -0500 | Rating Details | |
| 2024-10-15 22:40:24 -0500 | Rating Details | |
| 2024-10-15 21:20:57 -0500 | Rating Details | |
| 2024-10-15 21:11:33 -0500 | Rating Details | |
| 2024-10-15 20:51:01 -0500 | Rating Details | |
| 2024-10-15 19:51:19 -0500 | Rating Details | |
| 2024-10-16 19:45:56 -0500 | Rating Details | |
| 2024-10-16 17:48:37 -0500 | Rating Details | |
| 2024-10-16 13:51:53 -0500 | Rating Details | |
| 2024-10-16 10:19:51 -0500 | Rating Details | |
| 2024-10-16 09:47:50 -0500 | Rating Details | |
| 2024-10-16 08:59:05 -0500 | Rating Details | |
| 2024-10-16 06:12:07 -0500 | Rating Details | |
| 2024-10-16 04:57:37 -0500 | Rating Details | |
| 2024-10-16 03:18:13 -0500 | Rating Details | |
| 2024-10-15 22:25:53 -0500 | Rating Details | |
| 2024-10-15 21:54:24 -0500 | Rating Details | |
| 2024-10-15 21:17:58 -0500 | Rating Details | |
| 2024-10-17 06:30:13 -0500 | Rating Details | |
| 2024-10-16 17:38:18 -0500 | Rating Details | |
| 2024-10-16 17:16:10 -0500 | Rating Details | |
| 2024-10-16 17:11:25 -0500 | Rating Details | |
| 2024-10-16 14:52:18 -0500 | Rating Details | |
| 2024-10-16 14:24:10 -0500 | Rating Details | |
| 2024-10-16 12:36:33 -0500 | Rating Details | |
| 2024-10-16 12:34:42 -0500 | Rating Details | |
| 2024-10-16 12:17:16 -0500 | Rating Details | |
| 2024-10-16 10:24:57 -0500 | Rating Details | |
| 2024-10-16 08:50:37 -0500 | Rating Details | |
| 2024-10-16 07:08:11 -0500 | Rating Details | |
| 2024-10-16 06:59:02 -0500 | Rating Details | |
| 2024-10-15 21:02:38 -0500 | Rating Details | |
| 2024-10-17 10:50:01 -0500 | Rating Details | |
| 2024-10-17 09:09:31 -0500 | Rating Details | |
| 2024-10-17 05:49:53 -0500 | Rating Details | |
| 2024-10-16 19:17:41 -0500 | Rating Details | |
| 2024-10-16 15:58:05 -0500 | Rating Details | |
| 2024-10-16 10:02:49 -0500 | Rating Details | |
| 2024-10-16 08:53:06 -0500 | Rating Details | |
| 2024-10-16 07:20:49 -0500 | Rating Details | |
| 2024-10-16 06:40:44 -0500 | Rating Details | |
| 2024-10-16 06:21:17 -0500 | Rating Details | |
| 2024-10-15 20:58:24 -0500 | Rating Details | |
| 2024-10-15 20:42:17 -0500 | Rating Details | |
| 2024-10-16 23:25:11 -0500 | Rating Details | |
| 2024-10-16 18:21:03 -0500 | Rating Details | |
| 2024-10-16 09:25:37 -0500 | Rating Details | |
| 2024-10-16 07:31:19 -0500 | Rating Details | |
| 2024-10-15 23:16:52 -0500 | Rating Details | |
| 2024-10-15 22:14:24 -0500 | Rating Details | |
| 2024-10-15 22:02:09 -0500 | Rating Details | |
| 2024-10-15 21:34:49 -0500 | Rating Details |